Article Versions Notes

Laudicella R, Albano D, Annunziata S, Calabrò D, Argiroffi G, Abenavoli E, Linguanti F, Albano D, Vento A, Bruno A, et al. Theragnostic Use of Radiolabelled Dota-Peptides in Meningioma: From Clinical Demand to Future Applications. Cancers. 2019; 11(10):1412. https://doi.org/10.3390/cancers11101412

Laudicella, Riccardo, Domenico Albano, Salvatore Annunziata, Diletta Calabrò, Giovanni Argiroffi, Elisabetta Abenavoli, Flavia Linguanti, Domenico Albano, Antonio Vento, Antonio Bruno, and et al. 2019. "Theragnostic Use of Radiolabelled Dota-Peptides in Meningioma: From Clinical Demand to Future Applications" Cancers 11, no. 10: 1412. https://doi.org/10.3390/cancers11101412

Laudicella, R., Albano, D., Annunziata, S., Calabrò, D., Argiroffi, G., Abenavoli, E., Linguanti, F., Albano, D., Vento, A., Bruno, A., Alongi, P., & Bauckneht, M. (2019). Theragnostic Use of Radiolabelled Dota-Peptides in Meningioma: From Clinical Demand to Future Applications. Cancers, 11(10), 1412. https://doi.org/10.3390/cancers11101412